Literature DB >> 30105792

Complications and early mortality in patients with acute promyelocytic leukemia treated in California.

Gwendolyn Ho1, Qian Li2, Ann Brunson2, Brian A Jonas2,3, Ted Wun2,3,4, Theresa H M Keegan2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30105792      PMCID： PMC6486372          DOI： 10.1002/ajh.25252

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   13.265


× No keyword cloud information.
  5 in total

1.  Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Authors:  Jae H Park; Baozhen Qiao; Katherine S Panageas; Maria J Schymura; Joseph G Jurcic; Todd L Rosenblat; Jessica K Altman; Dan Douer; Jacob M Rowe; Martin S Tallman
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

2.  Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia.

Authors:  Yingmei Zhang; Zhuo Zhang; Jinmei Li; Limin Li; Xueying Han; Lina Han; Longhu Hu; Shuye Wang; Yanhong Zhao; Xiaoxia Li; Ying Zhang; Shengjin Fan; Chengfang Lv; Yinghua Li; Yanhua Su; Hui Zhao; Xin Zhang; Jin Zhou
Journal:  Cancer       Date:  2012-08-28       Impact factor: 6.860

3.  Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Authors:  S Lehmann; A Ravn; L Carlsson; P Antunovic; S Deneberg; L Möllgård; A Rangert Derolf; D Stockelberg; U Tidefelt; A Wahlin; L Wennström; M Höglund; G Juliusson
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

4.  Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.

Authors:  Gwendolyn Ho; Ted Wun; Lori Muffly; Qian Li; Ann Brunson; Aaron S Rosenberg; Brian A Jonas; Theresa H M Keegan
Journal:  Cancer       Date:  2018-02-16       Impact factor: 6.921

5.  Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California.

Authors:  Renata Abrahão; Raul C Ribeiro; Bruno C Medeiros; Ruth H Keogh; Theresa H M Keegan
Journal:  Cancer       Date:  2015-08-11       Impact factor: 6.921
  5 in total
  5 in total

1.  Treatment Complications and Survival Among Children and Young Adults With Acute Lymphoblastic Leukemia.

Authors:  Elysia M Alvarez; Marcio Malogolowkin; Jeffrey S Hoch; Qian Li; Ann Brunson; Brad H Pollock; Lori Muffly; Ted Wun; Theresa H M Keegan
Journal:  JCO Oncol Pract       Date:  2020-06-11

2.  Regionalization of Acute Myeloid Leukemia Treatment in a Community-Based Population: Implementation and Early Results.

Authors:  Lisa Y Law; Stephen P Uong; Hyma T Vempaty; Vu H Nguyen; David Baer; Vincent X Liu; Lisa J Herrinton
Journal:  Perm J       Date:  2021-05

3.  Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?

Authors:  Prajwal Dhakal; Elizabeth Lyden; Venkat Rajasurya; Amer M Zeidan; Chakra Chaulagain; Krishna Gundabolu; Vijaya Raj Bhatt
Journal:  Leuk Lymphoma       Date:  2021-03-12

4.  Early mortality and survival improvements for adolescents and young adults with acute promyelocytic leukemia in California: an updated analysis.

Authors:  Renata Abrahão; Raul C Ribeiro; Marcio H Malogolowkin; Ted Wun; Theresa H M Keegan
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

5.  Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States.

Authors:  Jan Philipp Bewersdorf; Stephanie Prozora; Nikolai A Podoltsev; Rory M Shallis; Scott F Huntington; Natalia Neparidze; Rong Wang; Amer M Zeidan; Amy J Davidoff
Journal:  Blood Adv       Date:  2022-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.